Image of Dr Garry McDowell

Dr Garry McDowell

Pharmacy and Biomolecular Sciences

Faculty of Science

See My Tutor

ORCID

Garry McDowell is Head of Subject for Biomedical Sciences, with specialist interest in Clinical Biochemistry. Dr McDowell has clinical expertise in clinical biochemistry, in particular endocrinology, and is an internationally recognised expert in biomarker research in acute cardiology and heart failure.

Dr McDowell's research interest is focused on the translational aspects of the development and clinical validation of biomarkers for diagnostic and/or prognostic testing in cardiology.

His research underpins specific clinical objectives:
1. Generating and validating accurate and timely diagnostics for acute coronary syndromes.
2. Improving the diagnosis of acute coronary syndromes and heart failure.
3. Improved understanding of the prognostic roles of cardiac biomarkers.

I am also committed to collaborating and participating in important collaborative studies and have recently contributed to studies in predicting thrombosis in patients undergoing chemotherapy for breast cancer. In addition, other projects have explored the therapeutic potential of novel therapeutic approaches.

Publications are in high impact factor journals, for example:
Heart
British Journal of Cancer
Resuscitation
Journal of American College of Cardiology.

The Liverpool region has some of the highest rates of cardiac disease in the UK. The Liverpool Centre for Cardiovascular Science (LCCS), was founded in 2019 to bring together academics and clinicians with the aim of improving cardiac health. LCCS brings together the academic and clinical expertise of University of Liverpool, Liverpool John Moores University, Liverpool Heart and Chest Hospital NHS Foundation Trust and Liverpool Health Partners.

PhD Projects
Dr McDowell would be interested in receiving applications from potential self-funded PhD students. Potential projects are in:
1. Improving the predictive value of biomarkers for acute coronary syndromes
2. Improving the specificity of biomarkers for heart failure diagnosis
3. Use of artificial intelligence in the diagnosis of cardiovascular disease as a mechanism to combine clinical features, examination findings and biomarkers for the diagnosis of acute coronary syndromes and heart failure
4. Nutraceuticals in cardiovascular disease.

Degrees

Queens University Belfast, United Kingdom, PhD

Academic appointments

Head of Subject for Biomedical Sciences, Pharmacy and Biomolecular Sciences, Liverpool John Moores University, 2020 - present

Postgraduate training

Membership of Royal College of Pathologists (MRCPath), United Kingdom, Royal College of Pathologists, 1997 - 2003

Top